Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
CH0522213468
Wed, 21.12.2022
Achiko AG
Achiko AG Production and Sales Update
AptameX™ Gen 2 Covid-19 rapid calibration outperforms Abbott Pan Bio and Clugene’s rapid tests in Indonesia in validation tests.
Sample of 20 PCR Positive and 9 Negative samples, indicated a 100% match between AptameX™ Gen 2 product to PCR, whilst Clungene and Abbott’s Pan Bio were between 6% and 50% sensiti [ … ]
Wed, 21.12.2022
Achiko AG
Achiko AG Production and Sales Update
AptameX™ Gen 2 Covid-19 rapid calibration outperforms Abbott Pan Bio and Clugene’s rapid tests in Indonesia in validation tests.
Sample of 20 PCR Positive and 9 Negative samples, indicated a 100% match between AptameX™ Gen 2 product to PCR, whilst Clungene and Abbott’s Pan Bio were between 6% and 50% sensiti [ … ]
Fri, 25.11.2022
Achiko AG
Achiko AG issues a convocation notice to its shareholders for its Annual General Meeting on 20 December 2022
Zurich, 25 November 2022: Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) has issued a convocation notice to its shareholders for the Company's Annual General Meeting taking place at 10:00 a.m. (CET) on 2 [ … ]
Fri, 25.11.2022
Achiko AG
Achiko AG issues a convocation notice to its shareholders for its Annual General Meeting on 20 December 2022
Zurich, 25 November 2022: Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) has issued a convocation notice to its shareholders for the Company's Annual General Meeting taking place at 10:00 a.m. (CET) on 2 [ … ]
Mon, 14.11.2022
Achiko AG
Achiko AG Commences Commercial Deliveries in Indonesia
Commencing Commercial Deliveries of its Generation 2 AptameXTM Covid-19 tests kits with Nahdlatul Ulama DKI in Jakarta, Indonesia
Zurich, 14 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) is proud [ … ]
Mon, 14.11.2022
Achiko AG
Achiko AG Commences Commercial Deliveries in Indonesia
Commencing Commercial Deliveries of its Generation 2 AptameXTM Covid-19 tests kits with Nahdlatul Ulama DKI in Jakarta, Indonesia
Zurich, 14 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) is proud [ … ]
Wed, 02.11.2022
Achiko AG
Achiko AG Production and Company Update
Completing Production Pilot for Generation 2 of AptameXTM as a Precursor to Mass Commercial Production
Expect to Commence Delivery to Sales and Marketing Contract with Nahdlatul Ulama on Commencement of Mass Production
Zurich, 2 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: AC [ … ]
Wed, 02.11.2022
Achiko AG
Achiko AG Production and Company Update
Completing Production Pilot for Generation 2 of AptameXTM as a Precursor to Mass Commercial Production
Expect to Commence Delivery to Sales and Marketing Contract with Nahdlatul Ulama on Commencement of Mass Production
Zurich, 2 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: AC [ … ]
Fri, 07.10.2022
Achiko AG
Achiko AG Appoints New Chief Financial Officer
Zurich, 7 October 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) a healthcare technology company that is developing new innovations and disruptive diagnostic solutions that put people first announced that it has app [ … ]
Fri, 07.10.2022
Achiko AG
Achiko AG Appoints New Chief Financial Officer
Zurich, 7 October 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) a healthcare technology company that is developing new innovations and disruptive diagnostic solutions that put people first announced that it has app [ … ]